174 related articles for article (PubMed ID: 7524460)
1. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass.
Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
Ann Thorac Surg; 1994 Oct; 58(4):1036-9. PubMed ID: 7524460
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic function of aspirin-treated platelets vulnerable to cardiopulmonary bypass. Altered shear-induced pathway.
Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):813-8. PubMed ID: 7564450
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
4. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study.
Lavee J; Raviv Z; Smolinsky A; Savion N; Varon D; Goor DA; Mohr R
Ann Thorac Surg; 1993 Jan; 55(1):114-9. PubMed ID: 7678061
[TBL] [Abstract][Full Text] [Related]
5. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
Mohr R; Goor DA; Lusky A; Lavee J
Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass.
Harder MP; Eijsman L; Roozendaal KJ; van Oeveren W; Wildevuur CR
Ann Thorac Surg; 1991 Jun; 51(6):936-41. PubMed ID: 1710098
[TBL] [Abstract][Full Text] [Related]
7. Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study.
Lavee J; Savion N; Smolinsky A; Goor DA; Mohr R
Ann Thorac Surg; 1992 Mar; 53(3):477-81. PubMed ID: 1371665
[TBL] [Abstract][Full Text] [Related]
8. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
9. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
[TBL] [Abstract][Full Text] [Related]
11. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass.
van Oeveren W; Jansen NJ; Bidstrup BP; Royston D; Westaby S; Neuhof H; Wildevuur CR
Ann Thorac Surg; 1987 Dec; 44(6):640-5. PubMed ID: 2446574
[TBL] [Abstract][Full Text] [Related]
12. Platelet preservation during cardiopulmonary bypass with aprotinin.
Wildevuur CR; Eijsman L; Roozendaal KJ; Harder MP; Chang M; van Oeveren W
Eur J Cardiothorac Surg; 1989; 3(6):533-7; discussion 537-8. PubMed ID: 2483979
[TBL] [Abstract][Full Text] [Related]
13. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
14. Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
Santamaría A; Mateo J; Muñíz-Díaz E; Oliver A; Murillo J; Litvan H; Souto JC; Fontcuberta J
Haematologica; 2000 Apr; 85(4):381-5. PubMed ID: 10756363
[TBL] [Abstract][Full Text] [Related]
15. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
Blauhut B; Gross C; Necek S; Doran JE; Späth P; Lundsgaard-Hansen P
J Thorac Cardiovasc Surg; 1991 Jun; 101(6):958-67. PubMed ID: 1710008
[TBL] [Abstract][Full Text] [Related]
16. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations.
Murkin JM; Lux J; Shannon NA; Guiraudon GM; Menkis AH; McKenzie FN; Novick RJ
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):554-61. PubMed ID: 7508071
[TBL] [Abstract][Full Text] [Related]
17. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.
Ashraf S; Tian Y; Cowan D; Nair U; Chatrath R; Saunders NR; Watterson KG; Martin PG
Ann Thorac Surg; 1997 Jan; 63(1):68-73. PubMed ID: 8993243
[TBL] [Abstract][Full Text] [Related]
18. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass.
Tabuchi N; De Haan J; Boonstra PW; Huet RC; van Oeveren W
Eur J Cardiothorac Surg; 1994; 8(2):87-90. PubMed ID: 7513534
[TBL] [Abstract][Full Text] [Related]
19. Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate.
Shinfeld A; Zippel D; Lavee J; Lusky A; Shinar E; Savion N; Mohr R
Ann Thorac Surg; 1995 Apr; 59(4):872-6. PubMed ID: 7535040
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
